Table 3.
Characteristics of Clinical Responders vs Nonresponders in the Azithromycin Group
| Characteristic | Responders (n = 11) | Nonresponders (n = 10) | P Value |
|---|---|---|---|
| Female | 8 (73%) | 8 (80%) | .7 |
| Age,a years | 59.1 (12.6) | 60.5 (10.1) | .82 |
| BMI,a kg/m2 | 30.9 (3.1) | 26.3 (2.6) | < .01 |
| Asthma | 7 (64%) | 0 (0%) | < .01 |
| Reflux | 3 (27%) | 2 (20%) | .7 |
| Rhinitis | 1 (9%) | 1 (10%) | .94 |
| Baseline LCQa | 10.0 (3.0) | 10.0 (3.9) | .1 |
| Baseline CSSa | 6.4 (1.8) | 6.7 (2.2) | .72 |
| Baseline Fenob | 20.3 (0.58) | 20.3 (0.54) | .1 |
| Baseline sputum scorea | 3.7 (2.3) | 3.6 (2.1) | .1 |